Amic Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Amic General Information

Description

Manufacturer of biological products in Uppsala. The company's biological product manufacturing services is focused on development of in vitro diagnostic technologies for use in point-of-care and near-patient settings.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Uppsala Science Park Dag Hammarskjolds 52 B
  • 751 83 Uppsala
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 18-Jun-2008 000.00 Completed Generating Revenue
2. Later Stage VC (Series C) 20-Mar-2008 000.00 000.00 Completed Generating Revenue
1. Early Stage VC 08-Oct-2002 $3.22M $3.22M Completed Startup
To view Amic’s complete valuation and funding history, request access »

Amic Executive Team (2)

Name Title Board Seat Contact Info
Ove Öhman Co-Founder & Chief Executive Officer
Gunnar Axe Co-Founder
To view Amic’s complete executive team members history, request access »

Amic Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
InnovationsKapital Venture Capital Minority 000 0000 000000 0
Patricia Industries PE/Buyout Minority 000 0000 000000 0
To view Amic’s complete investors history, request access »